TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TELA

Tela Bio Inc

Healthcare · Medical Devices

1.30$ -2.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow TELA
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-385.6% -240.8% -165.2% -134.3% -103.3% -98.4% -69.9% -60.0% -35.2%
17.9% 15.1% 3.8% 2.9% 1.8% 2.9% 1.4% 1.5% 1.3%
4.6% 2.6% 3.0% 11.3% 12.4% 9.6% 8.6% 6.3% 4.7%
97.3% 52.9% 16.7% 21.8% 19.6% 16.7% – – –
1.8% -53.8% -40.4% -0.5% -11.8% -13.9% -2.9% -7.0% 1.9%
2.7% 18.9% 17.5% 0.9% 2.1% 4.5% 1.0% 1.4% 0.6%
-2.4% -18.8% -77.6% 50.1% -2.1% -4.5% -1.0% 6.4% 1.1%
521.1% 48.1% 424.3% 0.2% 0.1% -0.4% -0.5% – 0.1%
287.3% 302.2% 64.7% 54.9% 33.9% 15.8% 0.0% 0.0% 21.9%
620.4% 331.3% 424.3% 243.8% 2.0% 98.6% 79.2% 62.1% 32.1%
232.4% 71.7% 181.4% 159.7% -103.4% -4.6% 8.5% 8.6% -2.3%
-388.3% -259.7% -182.7% -135.2% -105.4% -102.9% -70.9% -61.4% -35.7%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?